—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
Clinical and Translational Allergy《临床与转化过敏》
月刊 - 英国
  • Clinical and Translational Allergy《临床与转化过敏》
  • SCIE外文期刊
  • 期发文量5
  • 国人占比21.43%
  • 知网外文库,维普目次
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:2区
    OA期刊:
  • 综述期刊:
    TOP期刊:
  • 期均国文:1
    环比增速:100.00%
  • 期刊信息

  • 研究方向:医学-ALLERGY过敏
  • 国际刊号:ISSN 2045-7022;EISSN 2045-7022
  • 期刊语言:英语
    出版地区:英国
  • 投稿网址:https://mc.manuscriptcentral.com/clintransall
  • 电子邮箱:
  • 期刊官网:https://onlinelibrary.wiley.com/journal/20457022
  • 作者指南:
  • 出版商网址:https://onlinelibrary.wiley.com/
  • 出版地址:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
  • 期刊简介:Clinical and Translational Allergy《临床与转化过敏》(月刊). Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as research letters, editorials, and letters to the editors.

  • 万维提示


  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://onlinelibrary.wiley.com/journal/20457022

    3、投稿网址:

    https://mc.manuscriptcentral.com/clintransall

    4、官网邮箱:ClinTransAll@wiley.com(编辑部)

    5、期刊刊期:月刊,一年出版12期。

    2022117日星期一

                                  

     

    投稿须知【官网信息】

     

    Clinical and Translational Allergy

    Author Guidelines

    1. SUBMISSION

    Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

    Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/clintransall

    Click here for more details on how to use ScholarOne.

    Data protection

    By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

    Preprint policy

    Please find the Wiley preprint policy here.

    This journal accepts articles previously published on preprint servers.

    Clinical and Translational Allergy will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

    For help with submissions, please contact the Editorial Office: ClinTransAll@wiley.com

    2. AIMS AND SCOPE

    The aim of Clinical and Translational Allergy is to advance, impact and communicate all aspects of the discipline of Allergy/Immunology including educational, translational and clinical research. Clinical and Translational Allergy is an international journal with contributors and readers from all countries.

    Clinical and Translational Allergy publishes editorials, position papers, review articles, original articles, letters, hypotheses, and correspondences. Articles are accepted purely on the basis of scientific merit and quality.

    3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

    i. Editorial

    Editorials are commissioned by the Editorial board. Submissions can be considered after consultation with the Editors-in-Chief only.

    Title: Should be informative that establishes a link to the article that the Editorial is written for

    Text: Should be strictly limited to 1,000 words (there will not be any abstracts or supplements)

    References: Maximum 9 references are allowed

    Figures and tables: Maximum two display items, figures and/or tables. Figure legends should be concise and should not be more than 100 words

    ii. Position Paper

    Position papers are written by authors selected by the EAACI Executive Committee.

    Title: Should be informative with less than 120 characters

    Short title: Should be less than 50 characters

    Keywords: Up to 5, listed in alphabetical order

    Abstract: 200 words of unstructured summary

    Text:

    Less than 4,500 words not including abstracts, figure legends and references (please supply a word count)

    Up to 100 references in the Journal's style (if more, justification should be provided)

    Figures and tables are important in position papers and up to 10 figures and/or tables (total) can be included in the text

    iii. Review Article

    Reviews should present an update of the most recent developments in a particular field of clinical allergy and immunologic research.

    Title: Should be informative with less than 120 characters

    Short title: Should be less than 50 characters

    Keywords: Up to 5, listed in alphabetical order

    Abstract: 200 words of unstructured summary

    Text:

    Up to 200 references in the Journal's style

    Figures and tables are important in review papers and up to 10 figures and/or tables (total) can be included in the text

    Please provide word counts

    ……

    更多详情:

    https://onlinelibrary.wiley.com/page/journal/20457022/homepage/author-guidelines







欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码